    <SEC-DOCUMENT>0001558370-24-007168-index.html : 20240508
    <SEC-HEADER>0001558370-24-007168.hdr.sgml : 20240508
    <ACCEPTANCE-DATETIME>20240507215640
    ACCESSION NUMBER:		0001558370-24-007168
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20231231
    FILED AS OF DATE:		20240508
    DATE AS OF CHANGE:		20240507
    EFFECTIVENESS DATE:		20240508

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
    		CENTRAL INDEX KEY:			0001130166
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		IRS NUMBER:				911766850
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	000-50626
    		FILM NUMBER:		24924030

    	BUSINESS ADDRESS:
    		STREET 1:		200 CONNELL DRIVE
    		STREET 2:		SUITE 1500
    		CITY:			BERKELEY HEIGHTS
    		STATE:			NJ
    		ZIP:			07922
    		BUSINESS PHONE:		908-517-7330

    	MAIL ADDRESS:
    		STREET 1:		200 CONNELL DRIVE
    		STREET 2:		SUITE 1500
    		CITY:			BERKELEY HEIGHTS
    		STATE:			NJ
    		ZIP:			07922

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
    		DATE OF NAME CHANGE:	20001218
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>cycc-20231231xars.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: cycc-20231231xars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>